TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Venus Medtech (Hangzhou), Inc. Class H ( (HK:2500) ) just unveiled an announcement.
Venus Medtech (Hangzhou) Inc. has announced a board meeting scheduled for August 28, 2025, to review and approve the interim results for the first half of 2025. The meeting will also consider the recommendation of an interim dividend and address other business matters, potentially impacting the company’s financial strategy and stakeholder interests.
More about Venus Medtech (Hangzhou), Inc. Class H
Venus Medtech (Hangzhou) Inc. is a company incorporated in the People’s Republic of China, operating in the medical technology industry. It focuses on developing and providing innovative medical devices, particularly in the cardiovascular field.
Average Trading Volume: 4,686,120
Technical Sentiment Signal: Sell
Current Market Cap: HK$1.98B
For an in-depth examination of 2500 stock, go to TipRanks’ Overview page.